Clostridioides difficile Infection in the Neurorehabilitation Setting: Importance of a Multidisciplinary Approach and Impact of the Fecal Microbiota Transplantation.|https://dx.doi.org/10.7759/cureus.46574
Fecal Microbiota Transplantation: History, Procedure and Regulatory Considerations.|https://dx.doi.org/10.1016/j.lpm.2023.104204
Clostridioides difficile infections; new treatments and future perspectives.|https://dx.doi.org/10.1097/MOG.0000000000000989
In vitro activity of fidaxomicin and combinations of fidaxomicin with other antibiotics against Clostridium perfringens strains isolated from dogs and cats.|https://dx.doi.org/10.1186/s12917-023-03801-2
Identification of an anti-CRISPR protein that inhibits the CRISPR-Cas type I-B system in Clostridioides difficile.|https://dx.doi.org/10.1128/msphere.00401-23
Multidisciplinary Treatment of Hepatocellular Carcinoma in 2023: Italian practice Treatment Guidelines of the Italian Association for the Study of the Liver (AISF), Italian Association of Medical Oncology (AIOM), Italian Association of Hepato-Bilio-Pancreatic Surgery (AICEP), Italian Association of Hospital Gastroenterologists (AIGO), Italian Association of Radiology and Clinical Oncology (AIRO), Italian Society of Pathological Anatomy and Diagnostic Cytology (SIAPeC-IAP), Italian Society of Surgery (SIC), Italian Society of Gastroenterology (SIGE), Italian Society of Medical and Interventional Radiology (SIRM), Italian Organ Transplant Society (SITO), and Association of Patients with Hepatitis and Liver Disease (EpaC) - Part I - Surgical treatments.|https://dx.doi.org/10.1016/j.dld.2023.10.029
Unveiling the inhibition mechanism of Clostridioides difficile by Bifidobacterium longum via multiomics approach.|https://dx.doi.org/10.3389/fmicb.2023.1293149
The gut microbiome dysbiosis and regulation by fecal microbiota transplantation: umbrella review.|https://dx.doi.org/10.3389/fmicb.2023.1286429
Vancomycin vs metronidazole use for the treatment of Clostridioides difficile infection in a tertiary care hospital in Saudi Arabia.|https://dx.doi.org/10.1016/j.heliyon.2023.e22053
Novel metal peroxide nanoboxes restrain Clostridioides difficile infection beyond the bactericidal and sporicidal activity.|https://dx.doi.org/10.1002/btm2.10593
The real efficacy of microbiota restoration following standard of care antimicrobial in patients with recurrent Clostridiodes difficile.|https://dx.doi.org/10.21037/tgh-23-46
Correction to: Role of previous systemic antibiotic therapy on the probability of recurrence after an initial episode of Clostridioides difficile infection treated with vancomycin.|https://dx.doi.org/10.1093/jacamr/dlad121
Fecal Microbiota, Live-jslm for the Prevention of Recurrent Clostridioides difficile Infection: Subgroup Analysis of PUNCH CD2 and PUNCH CD3.|https://dx.doi.org/10.1097/MCG.0000000000001947
Epidemiology, outcomes and risk factors for recurrence of Clostridioides difficile infections following allogeneic hematopoietic cell transplantation: a longitudinal retrospective multicenter study.|https://dx.doi.org/10.1038/s41409-023-02157-3
Inflammatory bowel disease and Clostridium difficile infection: clinical presentation, diagnosis, and management.|https://dx.doi.org/10.1177/17562848231207280
Assuring safety of fecal microbiota transplantation in the COVID-19 era: A single-center experience.|https://dx.doi.org/10.1002/jgh3.12979
